41 results on '"Fletcher, James L. K."'
Search Results
2. Initiation of Antiretroviral Therapy During Acute HIV-1 Infection Leads to a High Rate of Nonreactive HIV Serology
- Author
-
RV254/SEARCH010 Study Group, de Souza, Mark S., Pinyakorn, Suteeraporn, Akapirat, Siriwat, Pattanachaiwit, Supanit, Fletcher, James L. K., Chomchey, Nitiya, Kroon, Eugene D., Ubolyam, Sasiwimol, Michael, Nelson L., Robb, Merlin L., Phanuphak, Praphan, Kim, Jerome H., Phanuphak, Nittaya, and Ananworanich, Jintanat
- Published
- 2016
3. Absence of Cerebrospinal Fluid Signs of Neuronal Injury Before and After Immediate Antiretroviral Therapy in Acute HIV Infection
- Author
-
Peluso, Michael J., Valcour, Victor, Ananworanich, Jintanat, Sithinamsuwan, Pasiri, Chalermchai, Thep, Fletcher, James L. K., Lerdlum, Sukalya, Chomchey, Nitiya, Slike, Bonnie, Sailasuta, Napapon, Gisslén, Magnus, Zetterberg, Henrik, and Spudich, Serena
- Published
- 2015
4. Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection
- Author
-
Takata, Hiroshi, Buranapraditkun, Supranee, Kessing, Cari, Fletcher, James L. K., Muir, Roshell, Tardif, Virginie, Cartwright, Pearline, Vandergeeten, Claire, Bakeman, Wendy, Nichols, Carmen N., Pinyakorn, Suteeraporn, Hansasuta, Pokrath, Kroon, Eugene, Chalermchai, Thep, O’Connell, Robert, Kim, Jerome, Phanuphak, Nittaya, Robb, Merlin L., Michael, Nelson L., Chomont, Nicolas, Haddad, Elias K., Ananworanich, Jintanat, and Trautmann, Lydie
- Published
- 2017
- Full Text
- View/download PDF
5. Association between brain volumes and HAND in cART-naïve HIV+ individuals from Thailand
- Author
-
Heaps, Jodi M., Sithinamsuwan, Pasiri, Paul, Robert, Lerdlum, Sukalaya, Pothisri, Mantana, Clifford, David, Tipsuk, Somporn, Catella, Stephanie, Busovaca, Edgar, Fletcher, James L. K., Raudabaugh, Benjamin, Ratto-Kim, Silvia, Valcour, Victor, Ananworanich, Jintanat, and on behalf of the SEARCH 007/011 study groups
- Published
- 2015
- Full Text
- View/download PDF
6. Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND
- Author
-
Chalermchai, Thep, Valcour, Victor, Sithinamsuwan, Pasiri, Pinyakorn, Suteeraporn, Clifford, David, Paul, Robert H., Tipsuk, Somporn, Fletcher, James L. K., DeGruttola, Victor, Ratto-Kim, Silvia, Hutchings, Nicholas, Shikuma, Cecilia, Ananworanich, Jintanat, and The SEARCH 007 and 011 study groups
- Published
- 2013
- Full Text
- View/download PDF
7. Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy
- Author
-
Massanella, Marta, primary, Bakeman, Wendy, additional, Sithinamsuwan, Pasiri, additional, Fletcher, James L. K., additional, Chomchey, Nitiya, additional, Tipsuk, Somporn, additional, Chalermchai, Thep, additional, Routy, Jean-Pierre, additional, Ananworanich, Jintanat, additional, Valcour, Victor G., additional, and Chomont, Nicolas, additional
- Published
- 2019
- Full Text
- View/download PDF
8. Short Communication: Characterization of Cellular Immune Responses in Thai Individuals With and Without HIV-Associated Neurocognitive Disorders
- Author
-
Ratto-Kim, Silvia, Schuetz, Alexandra, Sithinamsuwan, Pasiri, Barber, John, Hutchings, Nicholas, Lerdlum, Sukalaya, Fletcher, James L. K., Phuang-Ngern, Yuwadee, Chuenarom, Weerawan, Tipsuk, Somporn, Pothisri, Mantana, Jadwattanakul, Tanate, Jirajariyavej, Supunnee, Sajjaweerawan, Chayada, Akapirat, Siriwat, Chalermchai, Thep, Suttichom, Duanghathai, Kaewboon, Boot, Prueksakaew, Peeriya, Karnsomlap, Putthachard, Clifford, David, Paul, Robert H., de Souza, Mark S., Kim, Jerome H., Ananworanich, Jintanat, and Valcour, Victor
- Subjects
Adult ,Male ,Immunity, Cellular ,AIDS Dementia Complex ,Immunology ,HIV Infections ,CD8-Positive T-Lymphocytes ,Middle Aged ,Viral Load ,Lymphocyte Activation ,Thailand ,Plasma ,Young Adult ,Humans ,Female - Abstract
HIV-associated neurocognitive disorder (HAND) remains a challenge despite antiretroviral therapy (ART), and has been linked to monocyte/macrophage (M/M) migration to the brain. Due to the potential impact of T cell effector mechanisms in eliminating activated/HIV-infected M/M, T cell activation may play a role in the development of HAND. We sought to investigate the relationship between cognition and both CD8(+) T cell activation (HLA-DR(+)/CD38(+)) and HIV-specific CD8(+) T cell responses at the time of HIV diagnosis and 12 months postinitiation of ART. CD8(+) T cell activation was increased in HAND compared to cognitive normal (NL) individuals and correlated directly with plasma viral load and inversely with the cognitive status. In addition, Gag-specific cytolytic activity (CD107a/b(+)) was decreased in HAND compared with NL individuals and correlated with their neurological testing, suggesting a potential role of cytotoxic CD8(+) T cells in the mechanism of HAND development.
- Published
- 2018
9. Very Early Initiation of Antiretroviral Therapy During Acute HIV Infection Is Associated With Normalized Levels of Immune Activation Markers in Cerebrospinal Fluid but Not in Plasma
- Author
-
Hellmuth, Joanna, primary, Slike, Bonnie M, additional, Sacdalan, Carlo, additional, Best, John, additional, Kroon, Eugene, additional, Phanuphak, Nittaya, additional, Fletcher, James L K, additional, Prueksakaew, Peeriya, additional, Jagodzinski, Linda L, additional, Valcour, Victor, additional, Robb, Merlin, additional, Ananworanich, Jintanat, additional, Allen, Isabel E, additional, Krebs, Shelly J, additional, and Spudich, Serena, additional
- Published
- 2019
- Full Text
- View/download PDF
10. Phyloanatomic characterization of the distinct T cell and monocyte contributions to the peripheral blood HIV population within the host.
- Author
-
RifeMagalis, Brittany, Strickland, Samantha L, Shank, Stephen D, Autissier, Patrick, Schuetz, Alexandra, Sithinamsuwan, Pasiri, Lerdlum, Sukalaya, Fletcher, James L K, Souza, Mark de, Ananworanich, Jintanat, Valcour, Victor, Group, The Search007 Study, Williams, Kenneth C, Pond, Sergei L Kosakovsky, RattoKim, Silvia, and Salemi, Marco
- Subjects
HIV ,T cells ,MONOCYTES ,NUCLEOTIDE sequencing ,CD4 lymphocyte count ,ANTIRETROVIRAL agents - Abstract
Human immunodeficiency virus (HIV) is a rapidly evolving virus, allowing its genetic sequence to act as a fingerprint for epidemiological processes among, as well as within, individual infected hosts. Though primarily infecting the CD4+ T-cell population, HIV can also be found in monocytes, an immune cell population that differs in several aspects from the canonical T-cell viral target. Using single genome viral sequencing and statistical phylogenetic inference, we investigated the viral RNA diversity and relative contribution of each of these immune cell types to the viral population within the peripheral blood. Results provide evidence of an increased prevalence of circulating monocytes harboring virus in individuals with high viral load in the absence of suppressive antiretroviral therapy. Bayesian phyloanatomic analysis of three of these individuals demonstrated a measurable role for these cells, but not the circulating T-cell population, as a source of cell-free virus in the plasma, supporting the hypothesis that these cells can act as an additional conduit of virus spread. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
11. High Number of Activated CD8+ T Cells Targeting HIV Antigens Are Present in Cerebrospinal Fluid in Acute HIV Infection
- Author
-
Kessing, Cari F., primary, Spudich, Serena, additional, Valcour, Victor, additional, Cartwright, Pearline, additional, Chalermchai, Thep, additional, Fletcher, James L. K., additional, Takata, Hiroshi, additional, Nichols, Carmen, additional, Josey, Benjamin J., additional, Slike, Bonnie, additional, Krebs, Shelly J., additional, Sailsuta, Napapon, additional, Lerdlum, Sukalaya, additional, Jagodzinski, Linda, additional, Tipsuk, Somporn, additional, Suttichom, Duanghathai, additional, Rattanamanee, Somprartthana, additional, Zetterberg, Henrik, additional, Hellmuth, Joanna, additional, Phanuphak, Nittaya, additional, Robb, Merlin L., additional, Michael, Nelson L., additional, Ananworanich, Jintanat, additional, and Trautmann, Lydie, additional
- Published
- 2017
- Full Text
- View/download PDF
12. Initiation of Antiretroviral Therapy During Acute HIV-1 Infection Leads to a High Rate of Nonreactive HIV Serology
- Author
-
de Souza, Mark S., primary, Pinyakorn, Suteeraporn, additional, Akapirat, Siriwat, additional, Pattanachaiwit, Supanit, additional, Fletcher, James L. K., additional, Chomchey, Nitiya, additional, Kroon, Eugene D., additional, Ubolyam, Sasiwimol, additional, Michael, Nelson L., additional, Robb, Merlin L., additional, Phanuphak, Praphan, additional, Kim, Jerome H., additional, Phanuphak, Nittaya, additional, and Ananworanich, Jintanat, additional
- Published
- 2016
- Full Text
- View/download PDF
13. Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy
- Author
-
Sailasuta, Napapon, primary, Ananworanich, Jintanat, additional, Lerdlum, Sukalaya, additional, Sithinamsuwan, Pasiri, additional, Fletcher, James L. K., additional, Tipsuk, Somporn, additional, Pothisri, Mantana, additional, Jadwattanakul, Tanate, additional, Jirajariyavej, Supunnee, additional, Chalermchai, Thep, additional, Catella, Stephanie, additional, Busovaca, Edgar, additional, Desai, Akash, additional, Paul, Robert, additional, and Valcour, Victor, additional
- Published
- 2016
- Full Text
- View/download PDF
14. Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy
- Author
-
Kore, Idil, primary, Ananworanich, Jintanat, additional, Valcour, Victor, additional, Fletcher, James L. K., additional, Chalermchai, Thep, additional, Paul, Robert, additional, Reynolds, Jesse, additional, Tipsuk, Somporn, additional, Ubolyam, Sasiwimol, additional, Rattanamanee, Somprartthana, additional, Jagodzinski, Linda, additional, Kim, Jerome, additional, and Spudich, Serena, additional
- Published
- 2015
- Full Text
- View/download PDF
15. Characterization of Cellular Immune Responses in Thai Individuals With and Without HIV-Associated Neurocognitive Disorders.
- Author
-
Ratto-Kim, Silvia, Schuetz, Alexandra, Sithinamsuwan, Pasiri, Barber, John, Hutchings, Nicholas, Lerdlum, Sukalaya, Fletcher, James L. K., Phuang-Ngern, Yuwadee, Chuenarom, Weerawan, Tipsuk, Somporn, Pothisri, Mantana, Jadwattanakul, Tanate, Jirajariyavej, Supunnee, Sajjaweerawan, Chayada, Akapirat, Siriwat, Chalermchai, Thep, Suttichom, Duanghathai, Kaewboon, Boot, Prueksakaew, Peeriya, and Karnsomlap, Putthachard
- Abstract
HIV-associated neurocognitive disorder (HAND) remains a challenge despite antiretroviral therapy (ART), and has been linked to monocyte/macrophage (M/M) migration to the brain. Due to the potential impact of T cell effector mechanisms in eliminating activated/HIV-infected M/M, T cell activation may play a role in the development of HAND. We sought to investigate the relationship between cognition and both CD8
+ T cell activation (HLA-DR+ /CD38+ ) and HIV-specific CD8+ T cell responses at the time of HIV diagnosis and 12 months postinitiation of ART. CD8+ T cell activation was increased in HAND compared to cognitive normal (NL) individuals and correlated directly with plasma viral load and inversely with the cognitive status. In addition, Gag-specific cytolytic activity (CD107a/b+ ) was decreased in HAND compared with NL individuals and correlated with their neurological testing, suggesting a potential role of cytotoxic CD8+ T cells in the mechanism of HAND development. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
16. Acute Retroviral Syndrome Is Associated With High Viral Burden, CD4 Depletion, and Immune Activation in Systemic and Tissue Compartments.
- Author
-
Crowell, Trevor A, Colby, Donn J, Pinyakorn, Suteeraporn, Fletcher, James L K, Kroon, Eugène, Schuetz, Alexandra, Krebs, Shelly J, Slike, Bonnie M, Leyre, Louise, and Chomont, Nicolas
- Subjects
HIV infection complications ,AIDS ,HIV-positive persons ,PROBABILITY theory ,SYNDROMES ,VIRAL load ,ANTIRETROVIRAL agents ,TREATMENT effectiveness ,CD4 lymphocyte count ,PHARMACODYNAMICS - Abstract
Background. Many individuals with acute human immunodeficiency virus infection (AHI) experience acute retroviral syndrome (ARS), which is associated with adverse long-term clinical outcomes. Methods. Participants presenting for voluntary human immunodeficiency virus (HIV) testing were enrolled during AHI in Bangkok, Thailand. ARS was defined by ≥3 qualifying signs/symptoms. HIV burden, immunophenotypes, and biomarkers were stratified by ARS diagnosis at enrollment and after up to 96 weeks of antiretroviral therapy (ART). Results. From 212 382 samples screened, 430 participants were enrolled during AHI, including 335 (78%) with ARS. Median age was 26 years and 416 (97%) were men. Sixty (14%) underwent sigmoid biopsy and 105 (24%) underwent lumbar puncture during AHI. Common symptoms included fever (93%), fatigue (79%), pharyngitis (67%), and headache (64%). Compared to those without ARS, participants with ARS were in later Fiebig stages with higher HIV RNA in blood, colon, and cerebrospinal fluid; higher total HIV DNA in blood; CD4 depletion in blood and colon; and elevated plasma tumor necrosis factor alpha (TNF-α), C-reactive protein, and D-dimer (all P < .05). Subgroup analyses of Fiebig I/II participants (95 with ARS, 69 without) demonstrated similar findings. After 96 weeks of ART, TNF-α and interleukin 6 were elevated in the ARS group (P < .05) but other biomarkers equilibrated. Conclusions. ARS was associated with high viral burden, CD4 depletion, and immune activation across multiple body compartments during AHI and prior to ART. Persistent inflammation despite suppressive ART could contribute to increased morbidity in individuals who experience ARS. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
17. High Prevalence of Transmitted Drug Resistance in Acute HIV-Infected Thai Men Who Have Sex With Men
- Author
-
Ananworanich, Jintanat, primary, Sirivichayakul, Sunee, additional, Pinyakorn, Suteeraporn, additional, Crowell, Trevor A., additional, Trichavaroj, Rapee, additional, Weerayingyong, Jessica, additional, Chomchey, Nitiya, additional, Fletcher, James L. K., additional, van Griensven, Frits, additional, Phanuphak, Praphan, additional, Robb, Merlin L., additional, Michael, Nelson L., additional, Kim, Jerome H., additional, and Phanuphak, Nittaya, additional
- Published
- 2015
- Full Text
- View/download PDF
18. Acute HIV infection detection and immediate treatment estimated to reduce transmission by 89% among men who have sex with men in Bangkok.
- Author
-
Kroon, Eugène D. M. B., Phanuphak, Nittaya, Shattock, Andrew J., Fletcher, James L. K., Pinyakorn, Suteeraporn, Chomchey, Nitiya, Akapirat, Siriwat, de Souza, Mark S., Robb, Merlin L., Kim, Jerome H., van Griensven, Frits, Ananworanich, Jintanat, and Wilson, David P.
- Subjects
DIAGNOSIS of HIV infections ,HIV infections ,THERAPEUTICS ,ANTIRETROVIRAL agents ,MEN who have sex with men ,HIV infection transmission ,HEALTH - Abstract
Introduction: Antiretroviral treatment (ART) reduces HIV transmission. Despite increased ART coverage, incidence remains high among men who have sex with men (MSM) in many places. Acute HIV infection (AHI) is characterized by high viral replication and increased infectiousness. We estimated the feasible reduction in transmission by targeting MSM with AHI for early ART. Methods: We recruited a cohort of 88 MSM with AHI in Bangkok, Thailand, who initiated ART immediately. A risk calculator based on viral load and reported behaviour, calibrated to Thai epidemiological data, was applied to estimate the number of onwards transmissions. This was compared with the expected number without early interventions. Results: Forty of the MSM were in 4th-generation AHI stages 1 and 2 (4thG stage 1, HIV nucleic acid testing (NAT)+/4thG immunoassay (IA)-/3rdG IA-; 4thG stage 2, NAT+/4thG IA+/3rdG IA-) while 48 tested positive on third-generation IA but had negative or indeterminate western blot (4thG stage 3). Mean plasma HIV RNA was 5.62 log
10 copies/ml. Any condomless sex in the four months preceding the study was reported by 83.7%, but decreased to 21.2% by 24 weeks on ART. After ART, 48/88 (54.6%) attained HIV RNA <50 copies/ml by week 8, increasing to 78/87 (89.7%), and 64/66 (97%) at weeks 24 and 48, respectively. The estimated number of onwards transmissions in the first year of infection would have been 27.3 (95% credible interval: 21.7-35.3) with no intervention, 8.3 (6.4-11.2) with post-diagnosis behaviour change only, 5.9 (4.4-7.9) with viral load reduction only and 3.1 (2.4-4.3) with both. The latter was associated with an 88.7% (83.8-91.1%) reduction in transmission. Conclusions: Disproportionate HIV transmission occurs during AHI. Diagnosis of AHI with early ART initiation can substantially reduce onwards transmission. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
19. Viral kinetics in untreated versus treated acute HIV infection in prospective cohort studies in Thailand.
- Author
-
Ananworanich, Jintanat, Eller, Leigh Anne, Pinyakorn, Suteeraporn, Kroon, Eugene, Sriplenchan, Somchai, Fletcher, James L. K., Suttichom, Duanghathai, Bryant, Christopher, Trichavaroj, Rapee, Dawson, Peter, Michael, Nelson, Phanuphak, Nittaya, and Robb, Merlin L.
- Subjects
HIV infections ,THERAPEUTICS ,ANTIRETROVIRAL agents ,VIRAL load ,PUBLIC health ,HIV infection transmission - Abstract
Introduction: The extent of viral replication during acute HIV infection (AHI) influences HIV disease progression. However, information comparing viral load (VL) kinetics with and without antiretroviral therapy (ART) in AHI is limited. The knowledge gained could inform preventive strategies aimed at reducing VL during AHI and therapeutic strategies to alter the viral kinetics that may enhance the likelihood of achieving HIV remission. Methods: The analysis utilized VL data captured during the first year of HIV infection from two studies in Thailand: the RV217 study (untreated AHI, 30 participants and 412 visits) and the RV254 study (treated AHI, 235 participants and 2803 visits). Fiebig stages were I/II (HIV RNA+, HIV IgM-) and Fiebig III/IV (HIV IgM+, Western blot-/indeterminate). Data were modelled utilizing spline effects within a linear mixed model, with a random intercept and slope to allow for between-subject variability and adjustment for the differences in variability between studies. The number of knots in the quadratic spline basis functions was determined by comparing models with differing numbers of knots via the Akaike Information Criterion. Models were fit using PROC GLIMMIX in SAS v9.3. Results: At enrolment, there were 24 Fiebig I/II and 6 Fiebig III/IV individuals in the untreated group and 137 Fiebig I/II and 98 Fiebig III/IV individuals in the treated group. Overall, the median age was 27.5 years old, most were male (89%), and CRF01_AE was the most common HIV clade (76%). By day 12 (4 days after ART in RV254), the untreated group had a 2.7-fold higher predicted mean VL level compared to those treated (predicted log VL 6.19 for RV217 and 5.76 for RV254, p = 0.05). These differences increased to 135-fold by day 30 (predicted log VL 4.89 for RV217 and 2.76 for RV254) and 1148-fold by day 120 (predicted log VL 4.68 for RV217 and 1.63 for RV254) (p < 0.0001 for both) until both curves were similarly flat at about day 150 (p = 0.17 between days 150 and 160). The VL trajectories were significantly different between Fiebig I/II and Fiebig III/IV participants when comparing the two groups and within the treated group (p < 0.001 for both). Conclusions: Initiating ART in AHI dramatically changed the trajectory of VL very early in the course of infection that could have implications for reducing transmission potential and enhancing responses to future HIV remission strategies. There is an urgency of initiating ART when acute infection is identified. New and inexpensive strategies to engage and test individuals at high risk for HIV as well as immediate treatment access will be needed to improve the treatment of acute infection globally. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
20. High Number of Activated CD8+ T Cells Targeting HIV Antigens Are Present in Cerebrospinal Fluid in Acute HIV Infection.
- Author
-
Kessing, Cari F., Spudich, Serena, Valcour, Victor, Cartwright, Pearline, Thep Chalermchai, Fletcher, James L. K., Hiroshi Takata, Nichols, Carmen, Josey, Benjamin J., Slike, Bonnie, Krebs, Shelly J., Sailsuta, Napapon, Sukalaya Lerdlum, Jagodzinski, Linda, Somporn Tipsuk, Duanghathai Suttichom, Somprartthana Rattanamanee, Zetterberg, Henrik, Hellmuth, Joanna, and Nittaya Phanuphak
- Published
- 2017
- Full Text
- View/download PDF
21. Delayed differentiation of potent effector CD8+ T cells reducing viremia and reservoir seeding in acute HIV infection.
- Author
-
Hiroshi Takata, Supranee Buranapraditkun, Kessing, Cari, Fletcher, James L. K., Muir, Roshell, Tardif, Virginie, Cartwright, Pearline, Vandergeeten, Claire, Bakeman, Wendy, Nichols, Carmen N., Suteeraporn Pinyakorn, Pokrath Hansasuta, Kroon, Eugene, Thep Chalermchai, O’Connell, Robert, Jerome Kim, Phanuphak, Nittaya, Robb, Merlin L., Michael, Nelson L., and Chomont, Nicolas
- Subjects
HIV ,CD8 antigen ,T cells ,ANTIRETROVIRAL agents ,HIV infections - Abstract
The article presents a study that analyzed the quality of HIV-specific CD8+ T cell responses emerging in the earliest stages of acute infection and assessed whether these responses could control viral replication and HIV reservoir seeding after antiretroviral therapy initiation. Topics discussed include HIV-specific CD8+ T cell expansion in the early stages of acute HIV-1 infection and loss of cytokine secretion and survival potential ofHIV-specific CD8+T cells during acute HIV infection.
- Published
- 2017
- Full Text
- View/download PDF
22. Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection.
- Author
-
Peluso, Michael J., Valcour, Victor, Phanuphak, Nittaya, Ananworanich, Jintanat, Fletcher, James L. K., Chalermchai, Thep, Krebs, Shelly J., Robb, Merlin L., Hellmuth, Joanna, Gisslén, Magnus, Zetterberg, Henrik, Spudich, Serena, and RV254SEARCH 010, RV304SEARCH 013, and SEARCH 011 Study Teams
- Published
- 2017
- Full Text
- View/download PDF
23. Neurologic signs and symptoms frequently manifest in acute HIV infection.
- Author
-
Hellmuth, Joanna, Fletcher, James L. K., Valcour, Victor, Kroon, Eugène, Ananworanich, Jintanat, Intasan, Jintana, Lerdlum, Sukalaya, Narvid, Jared, Pothisri, Mantana, Allen, Isabel, Krebs, Shelly J., Slike, Bonnie, Prueksakaew, Peeriya, Jagodzinski, Linda L., Puttamaswin, Suwanna, Phanuphak, Nittaya, Spudich, Serena, and SEARCH 010/RV254 Study Group
- Published
- 2016
- Full Text
- View/download PDF
24. Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV.
- Author
-
Valcour, Victor G., Spudich, Serena S., Sailasuta, Napapon, Phanuphak, Nittaya, Lerdlum, Sukalaya, Fletcher, James L. K., Kroon, Eugene D. M. B., Jagodzinski, Linda L., Allen, Isabel E., Adams, Collin L., Prueksakaew, Peeriya, Slike, Bonnie M., Hellmuth, Joanna M., Kim, Jerome H., Ananworanich, Jintanat, and null, null
- Subjects
ANTIRETROVIRAL agents ,NEUROLOGY ,INTEGRASE inhibitors ,CENTRAL nervous system diseases ,HIV infections ,HEALTH outcome assessment ,COMPARATIVE studies - Abstract
Objective: To compare central nervous system (CNS) outcomes in participants treated during acute HIV infection with standard combination antiretroviral therapy (cART) vs. cART plus integrase inhibitor and CCR5 antagonist (cART+). Design: 24-week randomized open-label prospective evaluation. Method: Participants were evaluated then randomized to initiate cART (efavirenz, tenofovir, and either emtricitabine or lamivudine) vs. cART+ (cART plus raltegravir and maraviroc) during acute HIV and re-evaluated at 4, 12 and 24 weeks. We examined plasma and CSF cytokines, HIV RNA levels, neurological and neuropsychological findings, and brain MRS across groups and compared to healthy controls. Results: At baseline, 62 participants were in Fiebig stages I-V. Randomized groups were similar for mean age (27 vs. 25, p = 0.137), gender (each 94% male), plasma log
10 HIV RNA (5.4 vs. 5.6, p = 0.382), CSF log10 HIV RNA (2.35 vs. 3.31, p = 0.561), and estimated duration of HIV (18 vs. 17 days, p = 0.546). Randomized arms did not differ at 24 weeks by any CNS outcome. Combining arms, all measures concurrent with antiretroviral treatment improved, for example, neuropsychological testing (mean NPZ-4 of -0.408 vs. 0.245, p<0.001) and inflammatory markers by MRS (e.g. mean frontal white matter (FWM) choline of 2.92 vs. 2.84, p = 0.045) at baseline and week 24, respectively. Plasma neopterin (p<0.001) and interferon gamma-induced protein 10 (IP-10) (p = 0.007) remained elevated in participants compared to controls but no statistically significant differences were seen in CSF cytokines compared to controls, despite individual variability among the HIV-infected group. Conclusions: A 24-week course of cART+ improved CNS related outcomes, but was not associated with measurable differences compared to standard cART. [ABSTRACT FROM AUTHOR]- Published
- 2015
- Full Text
- View/download PDF
25. HIV DNA in CD14+ reservoirs is associated with regional brain atrophy in patients naive to combination antiretroviral therapy.
- Author
-
Kallianpur, Kalpana J, Valcour, Victor G, Lerdlum, Sukalaya, Busovaca, Edgar, Agsalda, Melissa, Sithinamsuwan, Pasiri, Chalermchai, Thep, Fletcher, James L K, Tipsuk, Somporn, Shikuma, Cecilia M, Shiramizu, Bruce T, Ananworanich, Jintanat, and SEARCH 011 study group
- Published
- 2014
- Full Text
- View/download PDF
26. HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naïve Patients.
- Author
-
Valcour, Victor G., Ananworanich, Jintanat, Agsalda, Melissa, Sailasuta, Napapon, Chalermchai, Thep, Schuetz, Alexandra, Shikuma, Cecilia, Liang, Chin-Yuan, Jirajariyavej, Supunee, Sithinamsuwan, Pasiri, Tipsuk, Somporn, Clifford, David B., Paul, Robert, Fletcher, James L. K., Marovich, Mary A., Slike, Bonnie M., DeGruttola, Victor, and Shiramizu, Bruce
- Subjects
COGNITION disorder risk factors ,DNA ,HIV infections ,ANTIRETROVIRAL agents ,COMBINATION drug therapy ,MONOCYTES ,CEREBROSPINAL fluid ,CYTOKINES - Abstract
Objectives: Cognitive impairment remains frequent in HIV, despite combination antiretroviral therapy (cART). Leading theories implicate peripheral monocyte HIV DNA reservoirs as a mechanism for spread of the virus to the brain. These reservoirs remain present despite cART. The objective of this study was to determine if the level of HIV DNA in CD14
+ enriched monocytes predicted cognitive impairment and brain injury. Methods: We enrolled 61 cART-naïve HIV-infected Thais in a prospective study and measured HIV DNA in CD14+ enriched monocyte samples in a blinded fashion. We determined HAND diagnoses by consensus panel and all participants underwent magnetic resonance spectroscopy (MRS) to measure markers of brain injury. Immune activation was measured via cytokines in cerebrospinal fluid (CSF). Results: The mean (SD) age was 35 (6.9) years, CD4 T-lymphocyte count was 236 (139) and log10 plasma HIV RNA was 4.8 (0.73). Twenty-eight of 61 met HAND criteria. The log10 CD14+ HIV DNA was associated with HAND in unadjusted and adjusted models (p = 0.001). There was a 14.5 increased odds ratio for HAND per 1 log-value of HIV DNA (10-fold increase in copy number). Plasma CD14+ HIV DNA was associated with plasma and CSF neopterin (p = 0.023) and with MRS markers of neuronal injury (lower N-acetyl aspartate) and glial dysfunction (higher myoinositol) in multiple brain regions. Interpretation: Reservoir burden of HIV DNA in monocyte-enriched (CD14+ ) peripheral blood cells increases risk for HAND in treatment-naïve HIV+ subjects and is directly associated with CSF immune activation and both brain injury and glial dysfunction by MRS. [ABSTRACT FROM AUTHOR]- Published
- 2013
- Full Text
- View/download PDF
27. A novel acute HIV infection staging system based on 4th generation immunoassay.
- Author
-
Ananworanich, Jintanat, Fletcher, James L. K., Pinyakorn, Suteeraporn, Van Griensven, Frits, Vandergeeten, Claire, Schuetz, Alexandra, Pankam, Tippawan, Trichavaroj, Rapee, Akapirat, Siriwat, Chomchey, Nitiya, Phanuphak, Praphan, Chomont, Nicolas, Michael, Nelson L., Kim, Jerome H., and De Souza, Mark
- Subjects
- *
HIV infections , *HIV-positive persons , *CELL-mediated cytotoxicity , *ENZYME-linked immunosorbent assay , *LYMPHOCYTES , *KILLER cells , *IMMUNOASSAY - Abstract
Background: Fourth generation (4thG) immunoassay (IA) is becoming the standard HIV screening method but was not available when the Fiebig acute HIV infection (AHI) staging system was proposed. Here we evaluated AHI staging based on a 4thG IA (4thG staging). Findings: Screening for AHI was performed in real-time by pooled nucleic acid testing (NAT, n=48,828 samples) and sequential enzyme immunoassay (EIA, n=3,939 samples) identifying 63 subjects with non-reactive 2nd generation EIA (Fiebig stages I (n=25), II (n=7), III (n=29), IV (n=2)). The majority of samples tested (n=53) were subtype CRF_01AE (77%). NAT+ subjects were re-staged into three 4thG stages: stage 1 (n=20; 4th gen EIA-, 3rd gen EIA-), stage 2 (n=12; 4th gen EIA+, 3rd gen EIA-), stage 3 (n=31; 4th gen EIA+, 3rd gen EIA+, Western blot-/indeterminate). 4thG staging distinguishes groups of AHI subjects by time since presumed HIV exposure, pattern of CD8+ T, B and natural killer cell absolute numbers, and HIV RNA and DNA levels. This staging system further stratified Fiebig I subjects: 18 subjects in 4thG stage 1 had lower HIV RNA and DNA levels than 7 subjects in 4thG stage 2. Conclusions: Using 4th generation IA as part of AHI staging distinguishes groups of patients by time since exposure to HIV, lymphocyte numbers and HIV viral burden. It identifies two groups of Fiebig stage I subjects who display different levels of HIV RNA and DNA, which may have implication for HIV cure. 4th generation IA should be incorporated into AHI staging systems. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
28. Delayed differentiation of potent effector CD8+T cells reducing viremia and reservoir seeding in acute HIV infection
- Author
-
Takata, Hiroshi, Buranapraditkun, Supranee, Kessing, Cari, Fletcher, James L. K., Muir, Roshell, Tardif, Virginie, Cartwright, Pearline, Vandergeeten, Claire, Bakeman, Wendy, Nichols, Carmen N., Pinyakorn, Suteeraporn, Hansasuta, Pokrath, Kroon, Eugene, Chalermchai, Thep, O’Connell, Robert, Kim, Jerome, Phanuphak, Nittaya, Robb, Merlin L., Michael, Nelson L., Chomont, Nicolas, Haddad, Elias K., Ananworanich, Jintanat, and Trautmann, Lydie
- Abstract
Potent CD8+T cells endowed with effector functions able to kill HIV-producing cells and reduce the seeding of the HIV reservoir are only detected at peak viremia in acute HIV infection.
- Published
- 2017
- Full Text
- View/download PDF
29. Infrequent HIV Infection of Circulating Monocytes during Antiretroviral Therapy.
- Author
-
Massanella, Marta, Bakeman, Wendy, Sithinamsuwan, Pasiri, Fletcher, James L. K., Chomchey, Nitiya, Tipsuk, Somporn, Chalermchai, Thep, Routy, Jean-Pierre, Ananworanich, Jintanat, Valcour, Victor G., and Chomont, Nicolas
- Subjects
- *
HIV infections , *MONOCYTES , *ANTIRETROVIRAL agents , *T cells , *FLOW cytometry , *HIV - Abstract
Whereas human immunodeficiency virus (HIV) persists in tissue macrophages during antiretroviral therapy (ART), the role of circulating monocytes as HIV reservoirs remains controversial. Three magnetic bead selection methods and flow cytometry cell sorting were compared for their capacity to yield pure CD14+ monocyte populations. Cell sorting by flow cytometry provided the purest population of monocytes (median CD4+ T-cell contamination, 0.06%), and the levels of CD4+ T-cell contamination were positively correlated with the levels of integrated HIV DNA in the monocyte populations. Using cell sorting by flow cytometry, we assessed longitudinally the infection of monocytes and other cell subsets in a cohort of 29 Thai HIV-infected individuals. Low levels of HIV DNA were detected in a minority of monocyte fractions obtained before and after 1 year of ART (27% and 33%, respectively), whereas HIV DNA was readily detected in CD4+ T cells from all samples. Additional samples (2 to 5 years of ART) were obtained from 5 individuals in whom monocyte infection was previously detected. Whereas CD4+ T cells were infected at high levels at all time points, monocyte infection was inconsistent and absent in at least one longitudinal sample from 4/5 individuals. Our results indicate that infection of monocytes is infrequent and highlight the importance of using flow cytometry cell sorting to minimize contamination by CD4+ T cells. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
30. A randomized trial of vorinostat with treatment interruption after initiating antiretroviral therapy during acute HIV-1 infection.
- Author
-
Kroon EDMB, Ananworanich J, Pagliuzza A, Rhodes A, Phanuphak N, Trautmann L, Mitchell JL, Chintanaphol M, Intasan J, Pinyakorn S, Benjapornpong K, Chang JJ, Colby DJ, Chomchey N, Fletcher JLK, Eubanks K, Yang H, Kapson J, Dantanarayana A, Tennakoon S, Gorelick RJ, Maldarelli F, Robb ML, Kim JH, Spudich S, Chomont N, Phanuphak P, Lewin SR, and de Souza MS
- Abstract
Objective and Design: A randomized, open-label pilot study in individuals treated with antiretroviral therapy (ART) since acute HIV infection (AHI) with a regimen including a histone deacetylase inhibitor to induce HIV from latency and control HIV replication during subsequent treatment interruption (TI)., Methods: Fifteen participants who initiated ART at AHI were randomized to vorinostat/hydroxychloroquine/maraviroc (VHM) plus ART (n = 10) or ART alone (n = 5). The VHM arm received three 14-day vorinostat cycles within 10 weeks before TI. ART was resumed for plasma viral load (VL) > 1,000 HIV RNA copies/mL. Primary outcome was proportion of participants on VHM + ART versus ART only with VL < 50 copies/mL for 24 weeks after TI., Results: Fifteen participants on ART (median: 178 weeks: range 79-295) enrolled. Two on VHM + ART experienced serious adverse events. Fourteen participants underwent TI; all experienced VL rebound with no difference in time between arms: VHM + ART (n = 9) median: 4 weeks and ART only (n = 5) median: 5 weeks. VHM induced a 2.2-fold increase in VL (p = 0.008) by single-copy HIV RNA assay after the first cycle. Neopterin levels increased significantly following the first two cycles. After VHM treatment, the frequencies of peripheral blood mononuclear cells harboring total HIV DNA and cell-associated RNA were unchanged. All participants achieved VL suppression following ART re-initiation., Conclusions: Administration of VHM increased HIV VL in plasma, but this was not sustained. VHM did not impact time to viral rebound following TI and had no impact on the size of the HIV reservoir, suggesting that HIV reservoir elimination will require alternative treatment strategies., Competing Interests: NC has served on the scientific advisory board of Theravectys. JA has participated in advisory meetings for ViiV Healthcare, Merck, AbbVie, Gilead, and Roche. All other authors declare no competing interests., (© 2020 The Author(s).)
- Published
- 2020
- Full Text
- View/download PDF
31. Structural and functional brain imaging in acute HIV.
- Author
-
Samboju V, Philippi CL, Chan P, Cobigo Y, Fletcher JLK, Robb M, Hellmuth J, Benjapornpong K, Dumrongpisutikul N, Pothisri M, Paul R, Ananworanich J, Spudich S, and Valcour V
- Subjects
- Acute Disease, Adult, Diffusion Tensor Imaging methods, Female, Humans, Male, Brain diagnostic imaging, Brain physiopathology, HIV Infections diagnostic imaging, HIV Infections physiopathology, Magnetic Resonance Imaging methods
- Abstract
Background: HIV RNA is identified in cerebrospinal fluid (CSF) within eight days of estimated viral exposure. Neurological findings and impaired neuropsychological testing performance are documented in a subset of individuals with acute HIV infection (AHI). The purpose of this study was to determine whether microstructural white matter and resting-state functional connectivity (rsFC) are disrupted in AHI., Methods: We examined 49 AHI (100% male; mean age = 30 ± SD 9.9) and 23 HIV-uninfected Thai participants (78% male; age = 30 ± 5.5) with diffusion tensor imaging (DTI) and rsFC acquired at 3 Tesla, and four neuropsychological tests (summarized as NPZ-4). MRI for the AHI group was performed prior to combination antiretroviral treatment (ART) in 26 participants and on average two days (range:1-5) after ART in 23 participants. Fractional anisotropy (FA), mean (MD), axial (AD), and radial diffusivity (RD) were quantified for DTI. Seed-based voxelwise rsFC analyses were completed for the default mode (DMN), fronto-parietal, and salience and 6 subcortical networks. rsFC and DTI analyses were corrected for family-wise error, with voxelwise comparisons completed using t -tests. Group-specific voxelwise regressions were conducted to examine relationships between imaging indices, HIV disease variables, and treatment status., Results: The AHI group had a mean (SD) CD4 count of 421(234) cells/mm
3 plasma HIV RNA of 6.07(1.1) log10 copies/mL and estimated duration of infection of 20(5.5) days. Differences between AHI and CO groups did not meet statistical significance for DTI metrics. Within the AHI group, voxelwise analyses revealed associations between brief exposure to ART and higher FA and lower RD and MD bilaterally in the corpus callosum, corona radiata, and superior longitudinal fasciculus (p < 0.05). Diffusion indices were unrelated to clinical variables or NPZ-4. The AHI group had reduced rsFC between left parahippocampal cortex (PHC) of the DMN and left middle frontal gyrus compared to CO (p < 0.002). Within AHI, ART status was unrelated to rsFC. However, higher CD4 cell count associated with increased rsFC for the right lateral parietal and PHC seeds in the DMN. Direct associations were noted between NPZ-4 correspond to higher rsFC of the bilateral caudate seed (p < 0.002)., Conclusions: Study findings reveal minimal disruption to structural and functional brain integrity in the earliest stages of HIV. Longitudinal studies are needed to determine if treatment with ART initiated in AHI is sufficient to prevent the evolution of brain dysfunction identified in chronically infected individuals.- Published
- 2018
- Full Text
- View/download PDF
32. High Number of Activated CD8+ T Cells Targeting HIV Antigens Are Present in Cerebrospinal Fluid in Acute HIV Infection.
- Author
-
Kessing CF, Spudich S, Valcour V, Cartwright P, Chalermchai T, Fletcher JL, Takata H, Nichols C, Josey BJ, Slike B, Krebs SJ, Sailsuta N, Lerdlum S, Jagodzinski L, Tipsuk S, Suttichom D, Rattanamanee S, Zetterberg H, Hellmuth J, Phanuphak N, Robb ML, Michael NL, Ananworanich J, and Trautmann L
- Subjects
- Humans, Immunophenotyping, CD8-Positive T-Lymphocytes immunology, Cerebrospinal Fluid cytology, Cerebrospinal Fluid immunology, HIV Antigens immunology, HIV Infections immunology, HIV Infections pathology, T-Lymphocyte Subsets immunology
- Abstract
Background: Central nervous system (CNS) infiltration by CD8 T cells is associated with neuroinflammation in many neurodegenerative diseases, including HIV-associated dementia. However, the role of CD8 T cells in the CNS during acute HIV infection (AHI) is unknown., Methods: We analyzed the phenotype, gene expression, T cell receptor (TCR) repertoire, and HIV specificity of CD8 T cells in cerebrospinal fluid (CSF) of a unique cohort captured during the earliest stages of AHI (n = 26), chronic (n = 23), and uninfected (n = 8)., Results: CSF CD8 T cells were elevated in AHI compared with uninfected controls. The frequency of activated CSF CD8 T cells positively correlated to CSF HIV RNA and to markers of CNS inflammation. In contrast, activated CSF CD8 T cells during chronic HIV infection were associated with markers of neurological injury and microglial activation. CSF CD8 T cells in AHI exhibited increased functional gene expression profiles associated with CD8 T cells effector function, proliferation, and TCR signaling, a unique restricted TCR Vbeta repertoire and contained HIV-specific CD8 T cells directed to unique HIV epitopes compared with the periphery., Conclusions: These results suggest that CSF CD8 T cells in AHI expanding in the CNS are functional and directed against HIV antigens. These cells could thus play a beneficial role protective of injury seen in chronic HIV infection if combination antiretroviral therapy is initiated early.
- Published
- 2017
- Full Text
- View/download PDF
33. Delayed differentiation of potent effector CD8 + T cells reducing viremia and reservoir seeding in acute HIV infection.
- Author
-
Takata H, Buranapraditkun S, Kessing C, Fletcher JL, Muir R, Tardif V, Cartwright P, Vandergeeten C, Bakeman W, Nichols CN, Pinyakorn S, Hansasuta P, Kroon E, Chalermchai T, O'Connell R, Kim J, Phanuphak N, Robb ML, Michael NL, Chomont N, Haddad EK, Ananworanich J, and Trautmann L
- Subjects
- Acute Disease, Adult, Antiretroviral Therapy, Highly Active, Cell Proliferation, Cytokines metabolism, Female, HIV Infections drug therapy, HIV Infections pathology, Humans, Male, Survival Analysis, Viral Load, Viremia virology, CD8-Positive T-Lymphocytes immunology, Cell Differentiation, Disease Reservoirs virology, HIV Infections immunology, HIV Infections virology, Viremia immunology
- Abstract
CD8
+ T cells play a critical role in controlling HIV viremia and could be important in reducing HIV-infected cells in approaches to eradicate HIV. The simian immunodeficiency virus model provided the proof of concept for a CD8+ T cell-mediated reservoir clearance but showed conflicting evidence on the role of these cells to eliminate HIV-infected cells. In humans, HIV-specific CD8+ T cell responses have not been associated with a reduction of the HIV-infected cell pool in vivo. We studied HIV-specific CD8+ T cells in the RV254 cohort of individuals initiating ART in the earliest stages of acute HIV infection (AHI). We showed that the HIV-specific CD8+ T cells generated as early as AHI stages 1 and 2 before peak viremia are delayed in expanding and acquiring effector functions but are endowed with higher memory potential. In contrast, the fully differentiated HIV-specific CD8+ T cells at peak viremia in AHI stage 3 were more prone to apoptosis but were associated with a steeper viral load decrease after ART initiation. Their capacity to persist in vivo after ART initiation correlated with a lower HIV DNA reservoir. These findings demonstrate that HIV-specific CD8+ T cell magnitude and differentiation are delayed in the earliest stages of infection. These results also demonstrate that potent HIV-specific CD8+ T cells contribute to the reduction of the pool of HIV-producing cells and the HIV reservoir seeding in vivo and provide the rationale to design interventions aiming at inducing these potent responses to cure HIV infection., (Copyright © 2017, American Association for the Advancement of Science.)- Published
- 2017
- Full Text
- View/download PDF
34. HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART.
- Author
-
Ananworanich J, Chomont N, Eller LA, Kroon E, Tovanabutra S, Bose M, Nau M, Fletcher JLK, Tipsuk S, Vandergeeten C, O'Connell RJ, Pinyakorn S, Michael N, Phanuphak N, and Robb ML
- Subjects
- Adult, Anti-HIV Agents pharmacology, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, Female, Genotype, HIV Infections diagnosis, HIV-1 classification, Humans, Leukocytes, Mononuclear virology, Male, RNA, Viral, Viral Load, Young Adult, Anti-HIV Agents therapeutic use, DNA, Viral, HIV Infections drug therapy, HIV Infections virology, HIV-1 physiology, Proviruses
- Abstract
HIV DNA is a marker of HIV persistence that predicts HIV progression and remission, but its kinetics in early acute HIV infection (AHI) is poorly understood. We longitudinally measured the frequency of peripheral blood mononuclear cells harboring total and integrated HIV DNA in 19 untreated and 71 treated AHI participants, for whom 50 were in the earliest Fiebig I/II (HIV IgM-) stage, that is ≤2weeks from infection. Without antiretroviral therapy (ART), HIV DNA peaked at 2weeks after enrollment, reaching a set-point 2weeks later with little change thereafter. There was a marked divergence of HIV DNA values between the untreated and treated groups that occurred within the first 2weeks of ART and increased with time. ART reduced total HIV DNA levels by 20-fold after 2weeks and 316-fold after 3years. Therefore, very early ART offers the opportunity to significantly reduce the frequency of cells harboring HIV DNA., (Copyright © 2016 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
35. Virologic failure is uncommon after treatment initiation during acute HIV infection.
- Author
-
Crowell TA, Phanuphak N, Pinyakorn S, Kroon E, Fletcher JL, Colby D, Tipsuk S, Karnsomlap P, Laopraynak N, O'Connell RJ, Robb ML, and Ananworanich J
- Subjects
- Adolescent, Adult, Animals, Female, Humans, Male, Middle Aged, Prospective Studies, Thailand, Treatment Failure, Young Adult, Anti-Retroviral Agents therapeutic use, Antiretroviral Therapy, Highly Active, HIV Infections drug therapy, Sustained Virologic Response
- Abstract
Objective: In chronic HIV infection, initiation of antiretroviral therapy (ART) typically induces swift HIV RNA declines and virologic suppression within 24 weeks. The objective of this study was to investigate viral dynamics and common criteria for treatment success after ART initiation during acute HIV infection (AHI)., Methods: Participants were prospectively enrolled and offered ART during AHI from May 2009-June 2015 in Bangkok, Thailand. Regimens included tenofovir, lamivudine or emtricitabine, and efavirenz with or without raltegravir and maraviroc. Participants were monitored for several HIV RNA end points: one-log reduction at week 2; two-log reduction at week 4; less than 1000 copies/ml at week 24; and less than 200 copies/ml at week 24. Factors associated with each end point, time to suppression, and virologic blips were explored., Results: Two hundred and sixty-four Thai participants initiated ART during AHI. Their median age was 27 years and 96% were men. At 2 weeks, 6.5% had not achieved a one-log reduction in HIV RNA. At 4 weeks, 11.0% had not achieved a two-log reduction. At 24 weeks, 1.1% had not achieved HIV RNA less than 1000 copies/ml and 1.5% had not achieved HIV RNA less than 200 copies/ml. Participants who initiated ART during Fiebig I demonstrated a shorter median time to virologic suppression than did all other stages combined, [4 (interquartile range 2-8) vs. 8 (interquartile range 4-12) weeks, P < 0.001] and 7.3% had subsequent blips (16.1% in other stages, P = 0.23)., Conclusion: Virologic failure is uncommon in individuals who initiate ART during AHI. ART initiation during AHI is efficacious and clinicians can monitor for virologic failure after 24 weeks of therapy.
- Published
- 2016
- Full Text
- View/download PDF
36. Impact of early cART in the gut during acute HIV infection.
- Author
-
Deleage C, Schuetz A, Alvord WG, Johnston L, Hao XP, Morcock DR, Rerknimitr R, Fletcher JL, Puttamaswin S, Phanuphak N, Dewar R, McCune JM, Sereti I, Robb M, Kim JH, Schacker TW, Hunt P, Lifson JD, Ananworanich J, and Estes JD
- Abstract
Early after HIV infection there is substantial depletion of CD4
+ T cells in the gastrointestinal (GI) tract lamina propria (LP), with associated epithelial barrier damage, leading to microbial translocation and systemic inflammation and immune activation. In this study, we analyzed these early events in the GI tract in a cohort of Thai acute HIV-infected patients and determined the effect of early combination antiretroviral treatment (cART). HIV-uninfected and chronically and acutely HIV-infected patients at different Fiebig stages (I-V) underwent colonic biopsies and then received cART. Immunohistochemistry and quantitative image analysis were performed on cross-sectional and longitudinal colon biopsy specimens (day 0 to week 96) to measure GI tract damage (infiltration of polymorphonuclear cells), inflammation (M×1, TNF-α), immune activation (Ki-67), and the CD4+ T cell population in the LP. The magnitude of GI tract damage, immune activation, and inflammation was significantly increased, with significantly depleted CD4+ T cells in the LP in all acutely infected groups prior to cART compared with HIV-uninfected control participants. While most patients treated during acute infection resolved GI tract inflammation and immune activation back to baseline levels after 24 weeks of cART, most acutely infected participants did not restore their CD4+ T cells after 96 weeks of cART.- Published
- 2016
- Full Text
- View/download PDF
37. Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy.
- Author
-
Sailasuta N, Ananworanich J, Lerdlum S, Sithinamsuwan P, Fletcher JL, Tipsuk S, Pothisri M, Jadwattanakul T, Jirajariyavej S, Chalermchai T, Catella S, Busovaca E, Desai A, Paul R, and Valcour V
- Subjects
- Adult, Aspartic Acid analogs & derivatives, Aspartic Acid metabolism, Biomarkers metabolism, Brain pathology, Choline metabolism, Cognition Disorders etiology, Cognition Disorders metabolism, Female, Humans, Male, Middle Aged, Anti-HIV Agents therapeutic use, Antiretroviral Therapy, Highly Active, Brain metabolism, HIV Infections drug therapy, HIV Infections metabolism, Magnetic Resonance Spectroscopy methods, Neuroglia metabolism, Neurons metabolism
- Abstract
Objective: Combination antiretroviral therapy (cART) can suppress plasma HIV RNA to undetectable levels; yet reports indicate persistent HIV-associated neurocognitive disorders (HAND) among treated individuals. We sought to investigate imaging correlates of incomplete cognitive recovery among individuals with chronic HIV., Methods: We used single voxel proton magnetic resonance spectroscopy in 4 regions of the brain to measure changes in neuronal and glia biomarkers in cART-naive subjects before (n = 59, 27 with HAND) and after 12 months of cART., Results: At baseline, we observed elevated total choline (CHO) in the basal ganglia (BG, P = 0.002) and in the posterior cingulate gyrus (PCG, P = 0.022) associated with HIV infection. Myo-inositol (MI) was elevated in the frontal white matter (FWM, P = 0.040). N-acetylaspartate was elevated in the BG (P = 0.047). Using a mixed model approach among all HIV-infected individuals, at 6 months, we observed decreased n- acetylaspartate in FWM (P = 0.031), decreased creatine in PCG (P = 0.026) and increased MI in frontal gray matter (FGM, P = 0.023). At 12 months, we observed an increase in BG MI (P = 0.038) and in FGM (P = 0.021). Compared to those with normal cognition, HAND cases had higher FGM MI (P = 0.014) at baseline. At 12 months, individuals that remained cognitively impaired compared with those without HAND exhibited elevated CHO in the PCG (P = 0.018) and decreased glutamate in both FWM (P = 0.027) and BG (P = 0.013)., Conclusions: cART started during chronic HIV is associated with reduced neuronal-glia and inflammatory markers. Alterations in CHO are noted among individuals who remain impaired after 12 months of cART.
- Published
- 2016
- Full Text
- View/download PDF
38. Neuropsychological Impairment in Acute HIV and the Effect of Immediate Antiretroviral Therapy.
- Author
-
Kore I, Ananworanich J, Valcour V, Fletcher JL, Chalermchai T, Paul R, Reynolds J, Tipsuk S, Ubolyam S, Rattanamanee S, Jagodzinski L, Kim J, and Spudich S
- Subjects
- Adult, Antiretroviral Therapy, Highly Active, Female, HIV Infections drug therapy, Humans, Longitudinal Studies, Male, Neuropsychological Tests, Prospective Studies, Thailand, Treatment Outcome, Young Adult, Anti-Retroviral Agents therapeutic use, HIV Infections pathology, HIV Infections psychology, Nervous System Diseases drug therapy, Nervous System Diseases pathology, Psychomotor Disorders drug therapy, Psychomotor Disorders physiopathology
- Abstract
Objective: To investigate neuropsychological performance (NP) during acute HIV infection (AHI) before and after combination antiretroviral therapy (cART)., Design: Prospective study of Thai AHI participants examined at 3 and 6 months after initiation of cART., Methods: Thirty-six AHI participants were evaluated pre-cART at median 19 days since HIV exposure and 3 and 6 months after cART with the Grooved Pegboard test, Color Trails 1 & 2 (CT1, CT2), and Trail Making Test A. Raw scores were standardized to 251 age- and education-matched HIV-uninfected Thais. To account for learning effects, change in NP performance was compared with that of controls at 6 months. Analyses included multivariable regression, nonparametric repeated measures analysis of variance, and Mann-Whitney U test., Results: Baseline NP scores for the AHI group were within normal range (z-scores range: -0.26 to -0.13). NP performance improved on CT1, CT2, and Trail Making Test A in the initial 3 months (P < 0.01) with no significant change during the last 3 months. Only improvement in CT1 was greater than that seen in controls at 6 months (P = 0.018). Participants who performed >1 SD below normative means on ≥2 tests (n = 8) exhibited higher baseline cerebrospinal fluid HIV RNA (P = 0.047) and had no improvement after cART., Conclusions: Most AHI individuals had normal NP performance, and early cART slightly improved their psychomotor function. However, approximately 25% had impaired NP performance, which correlated with higher cerebrospinal fluid HIV RNA, and these abnormalities were not reversed by early cART possibly indicating limited reversibility of cognitive impairment in a subset of AHI individuals.
- Published
- 2015
- Full Text
- View/download PDF
39. High prevalence of transmitted drug resistance in acute HIV-infected Thai men who have sex with men.
- Author
-
Ananworanich J, Sirivichayakul S, Pinyakorn S, Crowell TA, Trichavaroj R, Weerayingyong J, Chomchey N, Fletcher JL, van Griensven F, Phanuphak P, Robb ML, Michael NL, Kim JH, and Phanuphak N
- Subjects
- Adult, Cohort Studies, Female, Genotype, HIV genetics, HIV isolation & purification, Humans, Male, Prevalence, Prospective Studies, Thailand epidemiology, Young Adult, Drug Resistance, Viral, HIV drug effects, HIV Infections transmission, HIV Infections virology, Homosexuality, Male
- Abstract
: As use of antiretroviral therapy in Thailand increases, so does the potential for transmission of drug-resistant HIV. We describe the prevalence of WHO surveillance drug resistance mutations among 120 subjects who underwent genotypic testing during acute HIV infection in Bangkok, Thailand. In this cohort of predominantly men who have sex with men, we observed an overall transmitted drug resistance prevalence of 9.2%, including nucleoside/nucleotide analog reverse transcriptase inhibitor 5.0%, nonnucleoside analog reverse transcriptase inhibitor 3.4%, and protease inhibitor 3.4%. These prevalence estimates are higher than previous reports of transmitted drug resistance in Thailand. Baseline drug resistance testing may be warranted, particularly among men who have sex with men.
- Published
- 2015
- Full Text
- View/download PDF
40. Practice effect and normative data of an HIV-specific neuropsychological testing battery among healthy Thais.
- Author
-
Sithinamsuwan P, Hutchings N, Ananworanich J, Wendelken L, Saengtawan P, Paul R, Chomchey N, Fletcher JL, Chalermchai T, and Valcour V
- Subjects
- Adult, Aged, Asian People, Cohort Studies, Female, Humans, Longitudinal Studies, Male, Middle Aged, Psychomotor Performance, Reference Values, Thailand, HIV Infections psychology, Neuropsychological Tests
- Abstract
Objective: A longitudinal cohort study was conducted in Bangkok, Thailand between 2008 and 2013 in order to determine the practice effect of serial neuropsychological testing and establish normative data among normal (HIV-uninfected) Thai volunteers., Material and Method: The authors enrolled 511 cognitively healthy individuals (HIV-uninfected, no drug abuse or other previous/current neurological or psychological conditions) to assess baseline performance on a HIV-specific neuropsychological testing battery. Ninety-nine subjects were re-assessed at 6 and 12 months to evaluate practice effects., Results: The mean age of the 99 subjects completing longitudinal visits was 49.2 years and 53 were male. The authors identified improved mean raw scores on most neuropsychological tests with repeated measurements; however only change in WHO Auditory Verbal Learning Test (AVLT) scores (learning, attention, immediate and delayed recall tasks) met statistical significance, with larger differences seen between baseline and 6-month compared to 6 and 12 months follow-up. Older age correlated with poorer baseline raw score, and was a predictor of worse performance at 6 months and 12 months on several tasks. Level of education was associated with practice effects on several tests. No similar effects were observed with gender., Conclusion: The authors identified improved performance after repeated measurements revealing a significant practice effect on an HIV-specific neuropsychological testing battery employed in Bangkok, Thailand. Main predictors were age and educational attainment.
- Published
- 2014
41. A novel acute HIV infection staging system based on 4th generation immunoassay.
- Author
-
Ananworanich J, Fletcher JL, Pinyakorn S, van Griensven F, Vandergeeten C, Schuetz A, Pankam T, Trichavaroj R, Akapirat S, Chomchey N, Phanuphak P, Chomont N, Michael NL, Kim JH, and de Souza M
- Subjects
- Adult, B-Lymphocytes immunology, CD8-Positive T-Lymphocytes immunology, DNA, Viral blood, Female, HIV Infections immunology, Humans, Immunoassay methods, Killer Cells, Natural immunology, Male, RNA, Viral blood, Time Factors, Viral Load, HIV Infections diagnosis, HIV Infections pathology, Mass Screening methods, Severity of Illness Index
- Abstract
Background: Fourth generation (4thG) immunoassay (IA) is becoming the standard HIV screening method but was not available when the Fiebig acute HIV infection (AHI) staging system was proposed. Here we evaluated AHI staging based on a 4thG IA (4thG staging)., Findings: Screening for AHI was performed in real-time by pooled nucleic acid testing (NAT, n=48,828 samples) and sequential enzyme immunoassay (EIA, n=3,939 samples) identifying 63 subjects with non-reactive 2nd generation EIA (Fiebig stages I (n=25), II (n=7), III (n=29), IV (n=2)). The majority of samples tested (n=53) were subtype CRF_01AE (77%). NAT+ subjects were re-staged into three 4thG stages: stage 1 (n=20; 4th gen EIA-, 3rd gen EIA-), stage 2 (n=12; 4th gen EIA+, 3rd gen EIA-), stage 3 (n=31; 4th gen EIA+, 3rd gen EIA+, Western blot-/indeterminate). 4thG staging distinguishes groups of AHI subjects by time since presumed HIV exposure, pattern of CD8+ T, B and natural killer cell absolute numbers, and HIV RNA and DNA levels. This staging system further stratified Fiebig I subjects: 18 subjects in 4thG stage 1 had lower HIV RNA and DNA levels than 7 subjects in 4thG stage 2., Conclusions: Using 4th generation IA as part of AHI staging distinguishes groups of patients by time since exposure to HIV, lymphocyte numbers and HIV viral burden. It identifies two groups of Fiebig stage I subjects who display different levels of HIV RNA and DNA, which may have implication for HIV cure. 4th generation IA should be incorporated into AHI staging systems.
- Published
- 2013
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.